Management of pulmonary toxicity associated with immune checkpoint inhibitors Source: Eur Respir Rev, 28 (154) 190012; 10.1183/16000617.0012-2019 Year: 2019
Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective study Source: ERJ Open Res, 6 (1) 00165-2019; 10.1183/23120541.00165-2019 Year: 2020
Immune checkpoint inhibitor-associated interstitial lung diseases: some progress but still many issues Source: Eur Respir J, 50 (2) 1701319; 10.1183/13993003.01319-2017 Year: 2017
Emerging concern of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017
Late Breaking Abstract - Biological phenotypes of ARDS show differential expression of genes involved in oxidative phosphorylation and immunomodulation: an illustration for the need of personalized medicine in ARDS. Source: International Congress 2018 – Ventilation and lung imaging in critically ill patients Year: 2018
Late Breaking Abstract - Cardiovascular adverse events of drugs targeting IL-5 in severe asthma: a pharmacovigilance study Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020
Predictive biomarker of immune checkpoint inhibitors efficacy Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine Year: 2019
Aspirin reduces cardiovascular events in patients with pneumonia: a prior event rate ratio analysis in a large primary care database Source: Eur Respir J, 57 (2) 2002795; 10.1183/13993003.02795-2020 Year: 2021
Differences in acute response team call triggering with CREWS scoring: A retrospective analysis Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning Year: 2015
Rituximab-induced lung disease: a systematic literature review Source: Eur Respir J 2010; 35: 681-687 Year: 2010
QVA149 does not increase the risk of cardio- and cerebro-vascular events, pneumonia and exacerbation events compared with placebo: A network meta-analysis across multiple safety databases Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013
Role of biomarkers of systemic inflammation in the prediction of mortality and/or severe complications in community adquired pneumonia Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019
LSC 2011 Abstract: Suppression of antitumor immunity as a potential link between inflammation and cancer in COPD Source: Annual Congress 2011 - COPD: human studies Year: 2011
The efficacy of immune checkpoint inhibitors in thoracic malignancies Source: Eur Respir Rev, 30 (162) 200387; 10.1183/16000617.0387-2020 Year: 2021
Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance–pharmacodynamic study Source: Eur Respir J, 53 (5) 1802472; 10.1183/13993003.02472-2018 Year: 2019
The clinical benefits of immune checkpoint inhibitors for thymic carcinomas Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Late Breaking Abstract - A key endpoint in viral challenge models of asthma exacerbations Source: International Congress 2019 – Airway physiology Year: 2019
Extensive alveoalar lymphocyte apoptosis in pulmonary sarcoidosis (PS) followed by clinical improvement. Two distinct apoptosis presentations? Source: Eur Respir J 2004; 24: Suppl. 48, 551s Year: 2004
Evaluation of serial interferon-gamma release assay testing in lung cancer patients treated with immune checkpoint inhibitors Source: Virtual Congress 2021 – Challenges and advances in the diagnosis and clinical management of tuberculosis Year: 2021
Biomarkers for activation of the inflammatory and immune systems in the risk of mortality in critically-ill COVID-19 patients Source: Virtual Congress 2021 – Respiratory failure in COVID19 and beyond Year: 2021